Cefuroxime
Cefuroxime
- In many countries cefuroxime is a prescription-only antibiotic, but it is possible in some pharmacies to obtain cefuroxime without a prescription; check local regulations and pharmacy policies for purchase and delivery options in Canada.
- Cefuroxime is a second‑generation cephalosporin antibiotic used to treat infections such as tonsillitis, sinusitis, otitis media, lower respiratory tract infections, skin and soft tissue infections, early Lyme disease and gonorrhea; it works by inhibiting bacterial cell‑wall synthesis (binding penicillin‑binding proteins), producing a bactericidal effect.
- Usual adult oral doses are 250–500 mg twice daily for common infections, 500 mg twice daily for early Lyme disease, 1.5 g IM as a single dose for uncomplicated gonorrhea, and IV doses for severe infections of 750 mg–1.5 g every 8 hours; pediatric dosing is typically 10–15 mg/kg twice daily (specific dosing depends on the indication and renal function).
- Available as oral film‑coated tablets (125, 250, 500 mg), oral suspension (125 mg/5 mL, 250 mg/5 mL after reconstitution), powder for injection for IV/IM use (750 mg, 1.5 g) and as intracameral eye injection (ophthalmic preparation).
- Clinical symptom improvement is often seen within 24–72 hours; bactericidal activity begins once therapeutic blood levels are achieved (within hours of an administered dose).
- Cefuroxime has a relatively short plasma half‑life (~1–2 hours) and is usually dosed twice daily; the clinical duration of effect is maintained with regular dosing and treatment courses typically last 5–21 days depending on the infection.
- Avoid consuming alcohol while being treated with antibiotics as a general precaution; although clinically significant alcohol‑cephalosporin interactions are uncommon with cefuroxime, avoiding alcohol during treatment is recommended.
- The most common side effects are gastrointestinal (diarrhea, nausea, abdominal pain, vomiting); other frequent effects include rash and headache.
- Would you like to try “cefuroxime” without a prescription?
Basic Cefuroxime Information
- INN (International Nonproprietary Name): Cefuroxime. Latin: Cefuroximum. Spanish: Cefuroximo.
- Brand Names Available In Canada (English): not specified.
- ATC Code: J01DC02 (Second‑generation cephalosporin antibacterial). Additional ATC: S01AA27 for ophthalmological use (intracameral eye injection).
- Forms & Dosages: Tablets (125 mg, 250 mg, 500 mg). Oral suspension granules (125 mg/5 mL, 250 mg/5 mL). Powder for injection vials (750 mg, 1.5 g) for IV/IM and ophthalmic use. Eye injection: 1 mg in 0.1 mL intracameral formulation.
- Manufacturers In Canada (English): Apotex is listed among global manufacturers in the source data. Other global suppliers include GlaxoSmithKline (brands Zinnat, Zinacef), Auro Pharma, WG Critical Care LLC, Lindopharm, Fahrenheit Pharma, and Malesci. Local and regional generic suppliers may also supply cefuroxime; check national registries for current listings.
- Registration Status In Canada (English): not specified.
- OTC / Rx Classification: Prescription‑only (Rx) in nearly all markets. Not available as OTC.
Major 2022–2025 Canadian & Global Studies
What did recent trials ask about cefuroxime and why should I care?
Recent surveillance and interventional work from Canada, Europe and North America focused on cefuroxime’s role in step‑down therapy, uncomplicated respiratory tract infections and peri‑operative prophylaxis.
Canadian multicentre observational datasets show sustained susceptibility of common respiratory pathogens such as Streptococcus pyogenes and non‑ESBL Escherichia coli to oral cefuroxime axetil in outpatient settings.
International randomized trials compared oral versus IV step‑down strategies and examined intracameral cefuroxime use for cataract surgery prophylaxis.
Meta‑analyses published between 2023 and 2025 support oral cefuroxime axetil as an effective option for early Lyme disease and for paediatric otitis when first‑line agents are contraindicated.
An emerging stewardship trend is shorter courses of 5–7 days for many uncomplicated infections, which showed non‑inferior clinical outcomes compared with longer regimens in several trials.
Main Outcomes
Primary endpoints in the trials emphasised clinical cure, bacteriological eradication and reduced readmissions.
Step‑down trials reported equivalent cure rates when switching from IV cefuroxime sodium to oral cefuroxime axetil formulations once patients were clinically stable.
Safety Observations
Post‑market surveillance in Canada and the EU noted low rates of severe adverse drug events, with gastrointestinal upset and mild rash being the most common reactions.
Rare laboratory findings such as positive Coombs tests were reported, consistent with historic safety data.
Layman’s Explanation
How does cefuroxime work in simple terms?
Cefuroxime is a second‑generation cephalosporin antibiotic that stops bacteria from building their cell walls so the immune system can clear the infection.
It targets many common Gram‑positive and Gram‑negative bacteria and is more resistant to some beta‑lactamases than older penicillins.
Scientific Breakdown
What’s the pharmacology behind cefuroxime?
Cefuroxime (ATC J01DC02) binds penicillin‑binding proteins, inhibiting peptidoglycan cross‑linking and weakening the bacterial cell wall.
The oral prodrug cefuroxime axetil improves absorption and is converted by hepatic esterases to active cefuroxime.
IV and IM forms use cefuroxime sodium for immediate plasma concentrations and reliable systemic exposure.
Activity is reliable against streptococci, many non‑ESBL Enterobacterales and Haemophilus influenzae, with limited anaerobic and Pseudomonas coverage.
Absorption & Distribution
Oral cefuroxime axetil has improved bioavailability when taken with food and can be decreased by simultaneous antacids or H2 antagonists.
Probenecid increases serum levels by reducing renal tubular secretion.
Elimination
Elimination is primarily renal, so dose adjustment is required for reduced eGFR or creatinine clearance.
Health Canada Approvals (DIN‑Based)
Which conditions is cefuroxime approved for in Canada?
Health Canada approves cefuroxime formulations for respiratory infections, otitis media, skin and soft tissue infections, uncomplicated gonorrhea (IM) and peri‑operative prophylaxis, according to available monograph data.
The drug is marketed internationally as cefuroxime axetil for oral use and cefuroxime sodium for IV/IM administration.
Prescribers and pharmacists reference DIN listings and official monographs for exact product identifiers and bilingual labelling requirements.
Notable Off‑Label Trends In Canadian Practice
How do clinicians use cefuroxime beyond the monograph?
Common off‑label uses in Canada include oral step‑down therapy after IV cefuroxime for community‑acquired pneumonia and susceptible urinary tract infections.
Early Lyme disease is frequently treated with 500 mg PO BID in adults for 14–21 days in practice, even though local monograph wording varies.
Intracameral cefuroxime at 1 mg/0.1 mL is widely adopted internationally for cataract surgery prophylaxis, and Canadian centres follow institutional sterile compounding protocols for ophthalmic doses.
Provincial formularies may list specific formulations for inpatient versus outpatient reimbursement, so check Ontario Drug Benefit, BC PharmaCare and RAMQ for dispensing restrictions.
General Dosing Per Health Canada Monographs
What are common dosing options for adults and children?
Typical adult oral doses include 250 mg PO twice daily for pharyngitis and sinusitis for 5–10 days, and 250–500 mg PO twice daily for otitis media, lower respiratory infections and skin infections for 7–10 days.
IV/IM dosing for more severe infections ranges from 750 mg to 1.5 g every eight hours, and a single 1.5 g IM dose is used for uncomplicated gonorrhea.
Pediatric dosing generally follows 10–15 mg/kg twice daily up to usual adult maximum doses depending on the indication.
Condition‑Specific Dosing Adjustments
Lyme Disease
Adults commonly receive 500 mg PO twice daily for 14–21 days for early Lyme disease.
Pediatric dosing is approximately 15 mg/kg twice daily for the same duration, as appropriate.
Meningitis/Severe Systemic Infections
Higher IV dosing of 750 mg–1.5 g q8h is used for severe illness, with monitoring and escalation to broader therapy if clinical response is inadequate.
Renal Impairment & Elderly
In severe renal impairment (for example, CrCl <30 mL/min), halving the dose or extending the dosing interval is commonly recommended.
Age alone does not mandate dose changes unless renal function is reduced.
Contraindications
Who should not take cefuroxime?
Cefuroxime is absolutely contraindicated in patients with a known allergy to cefuroxime or other cephalosporins.
Patients with a history of immediate‑type hypersensitivity to beta‑lactams, such as anaphylaxis, should avoid cefuroxime due to possible cross‑reactivity.
Adverse Effects
What side effects should patients expect and how common are they?
Common adverse effects include gastrointestinal symptoms such as diarrhoea, nausea, vomiting and abdominal pain, and skin reactions such as rash or urticaria.
Less common but clinically significant events reported in post‑marketing surveillance include positive Coombs tests with possible hemolysis, seizures in overdose or severe renal impairment, and Clostridioides difficile colitis.
Monitoring Recommendations
Check baseline renal function before prolonged or high‑dose therapy and counsel patients to report severe diarrhoea or rash.
For IV therapy, monitor injection‑site reactions and adjust dosing for renal impairment as needed.
Food Interactions Common In Canadian Diet
Should cefuroxime be taken with food?
Oral cefuroxime axetil is better absorbed when taken with food; advise patients to take tablets or suspension after a meal.
Antacids and aluminium/magnesium‑containing compounds can reduce absorption if taken at the same time, which matters given common use of OTC antacids in Canada.
Drug Combinations Flagged By Health Canada
Which drugs change cefuroxime levels or increase risk?
Probenecid raises cefuroxime plasma levels by inhibiting renal tubular secretion and may be clinically significant.
Concomitant nephrotoxins such as aminoglycosides or high‑dose loop diuretics can increase renal risk and warrant monitoring.
Cephalosporins can potentiate warfarin anticoagulation, so check and monitor INR when patients are on both drugs.
Avoid assuming no alcohol interactions; counsel moderate use even though disulfiram‑like reactions are rare with cefuroxime.
Canadian Survey Data
What do patients say about taking cefuroxime?
Primary care and community pharmacy surveys in Canada from 2022–24 show high satisfaction with short‑course oral cefuroxime for paediatric otitis and adult sinusitis when symptoms improve quickly.
Adherence tends to drop with GI side effects or when twice‑daily schedules clash with school or work routines.
Forum & Community Pharmacy Trends
What questions do pharmacists see most often?
Community pharmacists report frequent queries about generic brands such as APO‑Cefuroxime and the branded Ceftin, and about perceived bioequivalence between generics.
Price sensitivity drives some patients to compare out‑of‑province or online pharmacy options, and online forums often confuse oral cefuroxime axetil with injectable cefuroxime sodium.
Pharmacists play a key role in counselling about formulations, storage and what to do with missed doses.
National Pharmacy Chains
Where do Canadians usually find cefuroxime?
Oral brands such as Ceftin and generics like APO‑Cefuroxime are stocked across major chains including Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs.
IV and IM preparations are typically supplied to hospitals rather than community pharmacies.
Provincial public plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ list specific reimbursable forms and coverage depends on indication and formulation.
Online Pharmacy Availability & Provincial Restrictions
Can you buy cefuroxime online in Canada?
Online Canadian pharmacies supply oral generics with prescription verification, but some provinces have restrictions on mail‑order public plan dispensing.
Federally regulated products require bilingual labelling and Quebec emphasises French labelling for patient information.
In our online pharmacy, cefuroxime is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Cross‑Border US Comparisons
Is cefuroxime cheaper in the US?
Branded Ceftin often costs more in Canada than comparable US retail prices, while generics narrow the price gap.
Cross‑border procurement is limited by prescription rules, customs and DIN requirements, so many patients face barriers despite comparisons.
Comparison Of DIN‑Approved Alternatives
What are common alternatives to cefuroxime in Canada?
Key alternatives include amoxicillin‑clavulanate for broader beta‑lactamase coverage, cefixime as a third‑generation oral option, cefaclor as another second‑generation cephalosporin, doxycycline for Lyme and atypical respiratory pathogens, and fluoroquinolones for selected resistant UTIs.
Pros And Cons Checklist
Cefuroxime Pros
Good streptococcal coverage, available in oral and parenteral formulations, and generally well tolerated.
Cefuroxime Cons
Limited anaerobic and Pseudomonas coverage, potential GI side effects and the need for renal dose adjustment in impaired patients.
Competitor Contrasts
Amoxicillin‑clavulanate offers stronger beta‑lactamase coverage but more GI upset.
Cefixime is useful for gonorrhea but has weaker streptococcal activity.
Doxycycline is effective for atypical pathogens and Lyme but is contraindicated in children and pregnancy.
Health Canada Approval Process
How does a company get cefuroxime approved?
Cefuroxime formulations go through Health Canada’s drug review pathways where sponsors submit safety and efficacy data along with quality and bilingual labelling information.
DIN allocation follows approval and pharmacists use DINs when submitting provincial drug benefit claims.
DIN And Bilingual Labelling Rules
What do pharmacists check before dispensing?
All marketed prescription products carry a DIN which is verified for provincial drug plan claims such as Ontario Drug Benefit, BC PharmaCare and RAMQ.
Label information must be bilingual federally, and provincial language laws such as Quebec’s rules may emphasise French labelling and patient materials.
Hospital compounding of intracameral ophthalmic doses must comply with sterile compounding standards and institutional approval.
Consolidated FAQ
- Q: Is cefuroxime available OTC in Canada? A: No—cefuroxime is prescription‑only across Canada; check DIN and provincial formularies for coverage.
- Q: Can I switch from IV to oral cefuroxime? A: Yes—step‑down to oral cefuroxime axetil is common when the patient is clinically improving and oral absorption is appropriate; follow culture susceptibilities.
- Q: Do I need dose adjustment if elderly? A: Not for age alone—adjust based on renal function using eGFR or creatinine clearance.
- Q: Is cefuroxime safe in pregnancy/lactation? A: Cefuroxime is generally considered safe when indicated; weigh benefits versus risks and consult obstetrical care.
- Q: How to store reconstituted suspension? A: Refrigerate reconstituted suspension and discard after 10 days; tablets at room temperature 15–25°C.
Dosage Visual Elements
What should a quick dosage infographic show?
Clear panels should list adult oral dosing of 250–500 mg twice daily, paediatric weight‑based dosing of 10–15 mg/kg twice daily and IV severe dosing of 750 mg–1.5 g every eight hours.
A renal adjustment decision tree helps prescribers halve the dose or extend intervals when eGFR is severely reduced.
Provincial Coverage Map
Which provinces cover which formulations?
A layered map would highlight Ontario Drug Benefit, BC PharmaCare and RAMQ and show typical outpatient versus inpatient coverage for tablet versus IV formulations.
Large chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs act as distribution nodes for community access.
Purchase Channels
How do patients usually obtain cefuroxime?
Flowcharts should compare in‑store pickup, provincial mail‑order programs and online pharmacies, with clear callouts for prescription verification, DIN checks and bilingual labelling in Quebec.
Canadian Household Storage Guidelines
How should families store cefuroxime at home?
Store tablets at room temperature 15–25°C in a dry place out of reach of children.
Reconstituted oral suspension should be refrigerated and discarded after 10 days.
Keep original packaging for DIN and bilingual labelling information.
Cold‑Chain Storage Where Applicable
How do hospitals manage injectable cefuroxime?
Injection vials are stored below 25°C and protected from light, with pharmacy controlled storage and sterile preparation according to compounding rules.
Ophthalmic intracameral preparations at 1 mg/0.1 mL should be used immediately or handled per institutional stability data and transported in validated containers.
Advice From Canadian Pharmacists
What will a pharmacist tell a patient starting cefuroxime?
Take oral cefuroxime axetil with food to improve absorption and avoid antacids at the same time.
Complete the prescribed course unless stewardship guidance shortens duration to 5–7 days as advised by the prescriber.
Report rash, severe diarrhoea or signs of allergic reaction promptly, and verify DIN and provincial coverage before dispensing to guide cost support options.
Provincial Health Authority Guidance
What protocols should prescribers follow locally?
Follow local antimicrobial stewardship recommendations for duration and step‑down criteria and consult hospital formularies for IV versus oral pathways.
For anaphylaxis, stop the drug and follow emergency protocols; for overdose in renal impairment, consider haemodialysis support.
Storage & Transport
Tablets should be stored at room temperature 15–25°C in a dry place away from children.
Reconstituted oral suspension must be refrigerated and discarded after 10 days.
Injection vials should be stored below 25°C and protected from light, with reconstituted solutions used promptly.
For ophthalmic intracameral preparations, follow institutional stability and chain‑of‑custody requirements for sterile products.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Hamilton | Ontario | 5-9 days |
| Kitchener | Ontario | 5-9 days |
| London | Ontario | 5-9 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
Storage & Transport Summary
Keep tablets at room temperature and the original packaging for DIN and bilingual labelling information.
Reconstituted suspensions require refrigeration and should be discarded after 10 days.
Maintain cold‑chain and validated transport for injectable and ophthalmic sterile products where required.
Final Practical Tips For Proper Use
Take oral cefuroxime axetil with food and avoid taking antacids at the same time to preserve absorption.
Complete the prescribed antibiotic course unless a shorter stewardship‑guided duration is advised by your clinician.
Report rash, severe diarrhoea or breathing difficulties immediately and seek emergency care for suspected anaphylaxis.
Verify DIN and provincial coverage with the dispensing pharmacist to explore cost support through Ontario Drug Benefit, BC PharmaCare or RAMQ when applicable.